Preface |
|
xix | |
Acknowledgments |
|
xxi | |
|
SECTION 1 Principles of Patient-Focused Therapy |
|
|
|
Introduction: How to Use This Casebook |
|
|
1 | (8) |
|
|
Active Learning Strategies |
|
|
9 | (4) |
|
|
|
Case Studies in Patient Communication |
|
|
13 | (12) |
|
|
|
Care Planning: A Component of the Patient Care Process |
|
|
25 | (8) |
|
|
|
Documentation of Pharmacist Interventions |
|
|
33 | (6) |
|
|
|
|
SECTION 2 Cardiovascular Disorders |
|
|
|
Cardiopulmonary Resuscitation |
|
|
39 | (3) |
|
|
|
|
42 | (3) |
|
|
|
Obstructive Sleep Apnea and Hypertension |
|
|
45 | (2) |
|
|
|
Hypertensive Urgency/Emergency |
|
|
47 | (2) |
|
|
|
49 | (4) |
|
|
Ischemic Heart Disease and Acute Coronary Syndrome |
|
|
53 | (3) |
|
|
|
Acute Myocardial Infarction |
|
|
56 | (2) |
|
|
|
|
58 | (3) |
|
|
|
61 | (2) |
|
|
Hypertrophic Cardiomyopathy |
|
|
63 | (2) |
|
|
|
|
65 | (3) |
|
|
|
|
68 | (4) |
|
|
|
|
72 | (2) |
|
|
|
74 | (2) |
|
|
Hyperlipidemia: Primary Prevention |
|
|
76 | (3) |
|
|
|
Hyperlipidemia: Secondary Prevention |
|
|
79 | (2) |
|
|
Peripheral Vascular Disease |
|
|
81 | (2) |
|
|
|
83 | (4) |
|
|
SECTION 3 Respiratory Disorders |
|
|
|
|
87 | (3) |
|
|
|
|
|
90 | (3) |
|
|
Chronic Obstructive Lung Disease |
|
|
93 | (2) |
|
|
|
95 | (4) |
|
|
|
SECTION 4 Gastrointestinal Disorders |
|
|
|
Gastroesophageal Reflux Disease |
|
|
99 | (3) |
|
|
|
102 | (2) |
|
|
|
NSAID-Induced Ulcer Disease |
|
|
104 | (2) |
|
|
|
Stress Ulcer Prophylaxis/Upper GI Hemorrhage |
|
|
106 | (3) |
|
|
|
|
109 | (2) |
|
|
|
111 | (3) |
|
|
|
|
114 | (2) |
|
|
|
|
116 | (2) |
|
|
|
|
118 | (2) |
|
|
|
Pediatric Gastroenteritis |
|
|
120 | (2) |
|
|
|
|
122 | (2) |
|
|
Ascites Management in Portal Hypertension and Cirrhosis |
|
|
124 | (2) |
|
|
|
126 | (2) |
|
|
|
128 | (2) |
|
|
|
130 | (3) |
|
|
|
|
133 | (2) |
|
|
|
Viral Hepatitis A Vaccination |
|
|
135 | (2) |
|
|
|
137 | (2) |
|
|
|
139 | (4) |
|
|
|
SECTION 5 Renal Disorders |
|
|
|
Drug-Induced Acute Renal Failure |
|
|
143 | (2) |
|
|
|
145 | (2) |
|
|
|
Progressive Renal Disease |
|
|
147 | (2) |
|
|
|
|
149 | (2) |
|
|
Chronic Glomerulonephritis |
|
|
151 | (3) |
|
|
Syndrome of Inappropriate Antidiuretic Hormone Release |
|
|
154 | (2) |
|
|
Hyperkalemia, Hyperphosphatemia, and Hypercalcemia |
|
|
156 | (2) |
|
|
Hypercalcemia of Malignancy |
|
|
158 | (3) |
|
|
|
Hypokalemia and Hypomagnesemia |
|
|
161 | (2) |
|
|
|
|
163 | (2) |
|
Kimberly A. Dornbrook-Lavender |
|
|
|
|
165 | (4) |
|
|
SECTION 6 Neurologic Disorders |
|
|
|
|
169 | (2) |
|
|
|
|
171 | (2) |
|
|
Generalized Tonic-Clonic Seizures |
|
|
173 | (2) |
|
|
|
|
175 | (2) |
|
|
|
Acute Management of the Brain Injury Patient |
|
|
177 | (2) |
|
|
|
179 | (2) |
|
|
|
|
181 | (3) |
|
|
|
184 | (3) |
|
|
|
SECTION 7 Psychiatric Disorders |
|
|
|
Attention-Deficit Hyperactivity Disorder |
|
|
187 | (2) |
|
William H. Benefield, Jr. |
|
|
Eating Disorders: Anorexia Nervosa |
|
|
189 | (2) |
|
|
|
191 | (2) |
|
|
|
|
193 | (2) |
|
|
|
195 | (2) |
|
|
|
197 | (3) |
|
William H. Benefield, Jr. |
|
|
|
|
200 | (2) |
|
|
|
|
202 | (3) |
|
|
William H. Benefield, Jr. |
|
|
Generalized Anxiety Disorder |
|
|
205 | (3) |
|
|
|
Obsessive-Compulsive Disorder |
|
|
208 | (2) |
|
|
|
|
210 | (3) |
|
|
|
SECTION 8 Endocrinologic Disorders |
|
|
|
Type 1 Diabetes Mellitus and Ketoacidosis |
|
|
213 | (3) |
|
|
|
Type 2 Diabetes Mellitus: New Onset |
|
|
216 | (2) |
|
|
Type 2 Diabetes Mellitus: Existing Disease |
|
|
218 | (3) |
|
|
|
Hyperthyroidism: Graves' Disease |
|
|
221 | (2) |
|
|
|
223 | (2) |
|
|
|
225 | (2) |
|
|
|
|
227 | (1) |
|
|
|
|
228 | (3) |
|
|
|
SECTION 9 Gynecologic Disorders |
|
|
|
|
231 | (2) |
|
|
Premenstrual Dysphoric Disorder |
|
|
233 | (3) |
|
|
|
Managing Menopausal Symptoms |
|
|
236 | (3) |
|
|
|
SECTION 10 Urologic Disorders |
|
|
|
|
239 | (2) |
|
|
Benign Prostatic Hyperplasia |
|
|
241 | (3) |
|
|
|
|
Neurogenic Bladder & Urinary Incontinence |
|
|
244 | (3) |
|
|
SECTION 11 Immunologic Disorders |
|
|
|
Systemic Lupus Erythematosus |
|
|
247 | (2) |
|
|
|
Solid Organ Transplantation |
|
|
249 | (4) |
|
|
SECTION 12 Bone and Joint Disorders |
|
|
|
|
253 | (2) |
|
|
|
255 | (2) |
|
|
|
|
257 | (3) |
|
|
|
260 | (3) |
|
|
SECTION 13 Disorders of the Eyes, Ears, Nose and Throat |
|
|
|
|
263 | (2) |
|
|
|
265 | (4) |
|
|
SECTION 14 Dermatologic Disorders |
|
|
|
|
269 | (2) |
|
|
|
|
271 | (2) |
|
|
|
|
273 | (2) |
|
|
|
Cutaneous Reaction to Drugs |
|
|
275 | (2) |
|
|
|
SECTION 15 Hematologic Disorders |
|
|
|
|
277 | (3) |
|
|
|
|
280 | (2) |
|
|
|
|
282 | (2) |
|
|
|
|
284 | (5) |
|
|
|
SECTION 16 Infectious Diseases |
|
|
|
Using Laboratory Tests in Infectious Disease |
|
|
289 | (2) |
|
|
|
|
291 | (2) |
|
|
Pediatric Cough Illness/Acute Bronchitis |
|
|
293 | (2) |
|
|
|
Prevention and Treatment of Influenza |
|
|
295 | (2) |
|
|
|
Community-Acquired Pneumonia |
|
|
297 | (3) |
|
|
|
300 | (1) |
|
|
|
Streptococcal Pharyngitis |
|
|
301 | (2) |
|
|
|
|
303 | (1) |
|
|
|
|
304 | (3) |
|
|
|
|
|
307 | (2) |
|
|
|
|
309 | (2) |
|
|
|
|
|
311 | (3) |
|
|
|
Clostridium Difficile-Associated Diarrhea |
|
|
314 | (2) |
|
|
|
Intra-Abdominal Infection |
|
|
316 | (2) |
|
|
|
Lower Urinary Tract Infection |
|
|
318 | (2) |
|
|
|
|
|
320 | (4) |
|
|
Pelvic Inflammatory Disease and Other Sexually-Transmitted Diseases |
|
|
324 | (3) |
|
|
|
|
327 | (1) |
|
|
|
Genital Herpes and Chlamydial Infections |
|
|
328 | (2) |
|
|
Osteomyelitis and Septic Arthritis |
|
|
330 | (3) |
|
|
|
|
333 | (2) |
|
|
|
|
335 | (2) |
|
|
|
337 | (2) |
|
|
|
339 | (2) |
|
|
Systemic Fungal Infection |
|
|
341 | (3) |
|
|
|
Infections in Immunocompromised Patients |
|
|
344 | (2) |
|
|
Antimicrobial Prophylaxis for Surgery |
|
|
346 | (2) |
|
|
|
|
348 | (2) |
|
|
|
|
350 | (2) |
|
|
Cytomegalovirus (CMV) Retinitis |
|
|
352 | (2) |
|
|
|
354 | (3) |
|
|
|
|
HIV and Hepatitis C Coinfection |
|
|
357 | (4) |
|
|
|
|
SECTION 17 Oncologic Disorders |
|
|
|
|
361 | (3) |
|
|
Non-Small Cell Lung Cancer |
|
|
364 | (3) |
|
|
|
|
367 | (2) |
|
|
|
369 | (2) |
|
|
|
371 | (2) |
|
|
|
373 | (3) |
|
|
|
376 | (2) |
|
|
|
|
Acute Lymphocytic Leukemia |
|
|
378 | (4) |
|
|
Chronic Myelogenous Leukemia |
|
|
382 | (2) |
|
|
|
|
384 | (2) |
|
|
|
Hematopoietic Stem Cell Transplantation |
|
|
386 | (5) |
|
|
SECTION 18 Nutrition and Nutritional Disorders |
|
|
|
|
391 | (3) |
|
|
|
394 | (3) |
|
|
|
|
397 | (4) |
|
|
SECTION 19 Emergency Preparedness and Response |
|
|
|
|
401 | (8) |
|
|
SECTION 20 Complementary and Alternative Therapies |
|
|
|
|
Appendix A: Conversion Factors and Anthropometrics |
|
409 | (6) |
Appendix B: Common Laboratory Tests |
|
415 | (6) |
Appendix C: Medical Abbreviations |
|
421 | (10) |
Appendix D: Samples Responses to Case Questions |
|
431 | |